The new cardioprotector Monohydroxyethylrutoside protects against doxorubicin-induced inflammatory effects in vitro

Besides its cardiotoxic effect, doxorubicin also elicits inflammatory effects in vivo. 7-Monohydroxyethylrutoside (monoHER) has recently been used as a protector against doxorubicin-induced cardiotoxicity in vivo. It is not known yet whether monoHER can also protect against doxorubicin-induced infla...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Abou El Hassan, M A I, Verheul, H M W, Jorna, A S, Schalkwijk, C, van Bezu, J, van der Vijgh, W J F, Bast, A
Médium: Artigo
Jazyk:Inglês
Vydáno: Nature Publishing Group 2003
Témata:
Experimental Therapeutics
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC2394271/
https://ncbi.nlm.nih.gov/pubmed/12865930
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/sj.bjc.6601022
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky